Type 1A diabetes induced by infection and immunization

Journal of Autoimmunity

Volumn 16, Issue 3, 2001, Pages 355-362

  Robles, David T ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2;

AUTOIMMUNITY; CONFERENCE PAPER; CONGENITAL RUBELLA SYNDROME; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC SUSCEPTIBILITY; IMMUNIZATION; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034982992     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0483     Document Type: Conference Paper

References (69)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Etiology and pathogenesis of human insulin-dependent diabetes mellitus
3. The NOD mouse model of type 1 diabetes: As good as it gets?
4. The BB/Wor rat and the balance hypothesis of autoimmunity
5. The polyglandular autoimmune syndromes
6. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21
7. Genetic homogeneity of autoimmune polyglandular disease type I
8. Localization of the APECED protein in distinct nuclear structures
9. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla
10. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasisectodermal dystrophy protein
11. Early expression of anti-insulin autoantibodies of man and the NOD mouse: Evidence for early determination of subsequent diabetes
12. Evidence for oligogenic inheritance of type 1A diabetes in a large Bedouin Arab family
13. Immunological heterogeneity in type I diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease
14. Heterogenity of type 1 diabetes: Analysis of twins in the United Kingdom and United States
15. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus
16. Genetic heterogeneity by age at onset of type I diabetes: Higher prevalence of patients with 0 susceptible heterodimers in adults than in children in the registry of Turin, Italy
17. Late progression to type 1 diabetes of discordant twins of patients with type 1 diabetes: Combined analysis of two twin series (United States and United Kingdom)
18. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats
19. Type I diabetes mellitus. A chronic autoimmune disease
20. The Melbourne Pre-Diabetes Study: Prediction of type 1 diabetes mellitus using antibody and metabolic testing
21. Dual parameter model for prediction of type 1 diabetes mellitus
22. Increased-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse
23. Twin-to-twin pancreas transplantation: Reversal and reenactment of the pathogenesis of type I diabetes
24. Incidence of insulin-dependent diabetes mellitus in Colorado
25. Apparent epidemic of insulin dependent diabetes mellitus in Midwestern Poland
26. Epidemiology of type I diabetes
27. Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5 years of age in Germany
28. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes
29. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies
30. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele
31. 0 AD. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells
32. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets
33. T-cell responses to enterovirus antigens in children with type 1 diabetes
34. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies
35. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study
36. Pancreatic islet-cell damage in children with fatal viral infections
37. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis
38. Virologic, immunologic and genetic factors in insulin-dependent diabetes mellitus
39. Coxsackieviruses and diabetes
40. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM
41. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children - No evidence of increased antibody frequency
42. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes
43. Autoimmunity in congenital rubella syndrome
44. The HLA system in congenital rubella patients with and without diabetes
45. Congenital rubella. Monoclonal antibody-defined T cell abnormalities in young adults
46. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus
47. Association between type 1 diabetes and hib vaccine. Causal relation is likely
48. Association between type 1 diabetes and Haemophilus influenzae type b vaccination: Birth cohort study
49. Lack of association between early childhood immunizations and beta-cell autoimmunity
50. The Swedish childhood diabetes study - A multivariate analysis of risk determinants for diabetes in different age groups
51. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization
52. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas
53. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood
54. Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada
55. Childhood immunizations and type 1 diabetes: Summary of an Institute for Vaccine Safety Workshop
56. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
57. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
58. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice
59. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
60. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
61. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy
62. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals
63. Immunologic 'vaccination' for the prevention of autoimmune diabetes mellitus (type 1A)
64. Insulin prophylaxis in individuals at high risk of type I diabetes
65. Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens
66. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice
67. Autoimmune islet damage mediated by insulin-specific T cells
68. Dual overlapping peptides recognized by insulin peptide B:9-23 reactive T cell receptor AV13S3 T cell clones of the NOD mouse
69. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library